Related references
Note: Only part of the references are listed.Increased transcriptional activity of milk-related genes following the active phase of experimental autoimmune encephalomyelitis and multiple sclerosis
David Otaegui et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad-based phenotypic profiling
Aaron B. Kantor et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Reduced CD4+ T-cell-specific gene expression in human type I diabetes mellitus
Tihamer Orban et al.
JOURNAL OF AUTOIMMUNITY (2007)
Lack of association between antimyelin antibodies and progression to multiple sclerosis
Jens Kuhle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur et al.
NATURE IMMUNOLOGY (2007)
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L. Kappos et al.
NEUROLOGY (2006)
T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients
Jun-ichi Satoh et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
MRI criteria for dissemination in space in patients with clinically isolated syndromes:: a multicentre follow-up study
T Korteweg et al.
LANCET NEUROLOGY (2006)
Modular transcriptional activity characterizes the initiation and progression of autoimmune encephalomyelitis
SE Baranzini et al.
JOURNAL OF IMMUNOLOGY (2005)
Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis
J Satoh et al.
NEUROBIOLOGY OF DISEASE (2005)
Transcription-based prediction of response to IFN beta using supervised computational methods
SE Baranzini et al.
PLOS BIOLOGY (2005)
Semi-supervised methods to predict patient survival from gene expression data
E Bair et al.
PLOS BIOLOGY (2004)
Intrinsic and extrinsic regulation of T lymphocyte quiescence
D Tzachanis et al.
LEUKEMIA & LYMPHOMA (2004)
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
T Berger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Regulation of quiescence in lymphocytes
I Yusuf et al.
TRENDS IN IMMUNOLOGY (2003)
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis
MHJ Vogt et al.
ANNALS OF NEUROLOGY (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Dissociating perceptual and conceptual implicit memory in multiple sclerosis patients
D Blum et al.
BRAIN AND COGNITION (2002)
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
PA Brex et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells
D Tzachanis et al.
NATURE IMMUNOLOGY (2001)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Normalized accurate measurement of longitudinal brain change
SM Smith et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2001)